newsfilter
← Latest News
GlobeNewswire·

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Praxis Precision Medicines' Compensation Committee granted restricted stock unit awards for 7,318 common stock shares to 29 new non-executive employees on August 3, 2026.
  • The awards were issued under the 2024 Inducement Plan as material inducements for employment in compliance with Nasdaq Listing Rule 5635(c)(4).
  • The plan is designated exclusively for granting equity to individuals who were not previously employed by Praxis or returned after a bona fide period of non-employment.
  • The restricted stock units will vest in four equal annual installments contingent upon the employees' continued employment with Praxis on each vesting date.